Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Viktor Brabec

Showing results (101-110 of 242) with videos related to

Pageof 25
Sort By:
Journal of Inorganic Biochemistry|October 21, 2021
A [Pt(cis-1,3-diaminocycloalkane)Cl<sub>2</sub>] analog exhibits hallmarks typical of immunogenic cell death inducers in model cancer cellsVojtech Novohradsky, Lenka Markova, Hana Kostrhunova, et al.
Journal of Inorganic Biochemistry|August 28, 2012
How to modify 7-azaindole to form cytotoxic Pt(II) complexes: highly in vitro anticancer effective cisplatin derivatives involving halogeno-substituted 7-azaindolePavel Štarha, Zdeněk Trávníček, Alexandr Popa, et al.
The FEBS Journal|January 13, 2006
Recognition of DNA modified by trans-[PtClNH(4-hydroxymethylpyridine)] by tumor suppressor protein p53 and character of DNA adducts of this cytotoxic complexKristýna Stehlíková, Jana Kaspárková, Olga Nováková, et al.
Chemico-Biological Interactions|August 1, 2024
Antimetastatic activity of (arene)ruthenium(II) complex of 4-aryl-4H-naphthopyranJitka Pracharova, Tereza Cyrikova, Michal Berecka, et al.
Journal of Medicinal Chemistry|November 11, 2020
Platinum(IV)-Estramustine Multiaction Prodrugs Are Effective Antiproliferative Agents against Prostate Cancer CellsSubhendu Karmakar, Hana Kostrhunova, Tereza Ctvrtlikova, et al.
Chemical Research in Toxicology|October 14, 2010
Different features of the DNA binding mode of antitumor cis-amminedichlorido(cyclohexylamine)platinum(II) (JM118) and cisplatin in vitroHana Kostrhunova, Oldrich Vrana, Tereza Suchankova, et al.
Spectrochimica Acta. Part A, Molecular and Biomolecular Spectroscopy|March 19, 2017
3-[(E)-(acridin-9'-ylmethylidene)amino]-1-substituted thioureas and their biological activityMichal Bečka, Mária Vilková, Othman Salem, et al.
Molecular Pharmacology|August 10, 2006
Molecular aspects of antitumor effects of a new platinum(IV) drugJana Kaspárková, Olga Nováková, Oldrich Vrána, et al.
Chemical Communications (Cambridge, England)|May 4, 2017
Somatostatin receptor-targeted organometallic iridium(iii) complexes as novel theranostic agentsVojtech Novohradsky, Ana Zamora, Albert Gandioso, et al.
Journal of Inorganic Biochemistry|April 24, 2018
New (arene)ruthenium(II) complexes of 4‑aryl‑4H‑naphthopyrans with anticancer and anti-vascular activitiesFlorian Schmitt, Jana Kasparkova, Viktor Brabec, et al.
Pageof 25

Showing results (101-110 of 242) with videos related to

Sort By:
Pageof 25
Journal of Inorganic Biochemistry|October 21, 2021
A [Pt(cis-1,3-diaminocycloalkane)Cl<sub>2</sub>] analog exhibits hallmarks typical of immunogenic cell death inducers in model cancer cellsVojtech Novohradsky, Lenka Markova, Hana Kostrhunova, et al.
Journal of Inorganic Biochemistry|August 28, 2012
How to modify 7-azaindole to form cytotoxic Pt(II) complexes: highly in vitro anticancer effective cisplatin derivatives involving halogeno-substituted 7-azaindolePavel Štarha, Zdeněk Trávníček, Alexandr Popa, et al.
The FEBS Journal|January 13, 2006
Recognition of DNA modified by trans-[PtClNH(4-hydroxymethylpyridine)] by tumor suppressor protein p53 and character of DNA adducts of this cytotoxic complexKristýna Stehlíková, Jana Kaspárková, Olga Nováková, et al.
Chemico-Biological Interactions|August 1, 2024
Antimetastatic activity of (arene)ruthenium(II) complex of 4-aryl-4H-naphthopyranJitka Pracharova, Tereza Cyrikova, Michal Berecka, et al.
Journal of Medicinal Chemistry|November 11, 2020
Platinum(IV)-Estramustine Multiaction Prodrugs Are Effective Antiproliferative Agents against Prostate Cancer CellsSubhendu Karmakar, Hana Kostrhunova, Tereza Ctvrtlikova, et al.
Chemical Research in Toxicology|October 14, 2010
Different features of the DNA binding mode of antitumor cis-amminedichlorido(cyclohexylamine)platinum(II) (JM118) and cisplatin in vitroHana Kostrhunova, Oldrich Vrana, Tereza Suchankova, et al.
Spectrochimica Acta. Part A, Molecular and Biomolecular Spectroscopy|March 19, 2017
3-[(E)-(acridin-9'-ylmethylidene)amino]-1-substituted thioureas and their biological activityMichal Bečka, Mária Vilková, Othman Salem, et al.
Molecular Pharmacology|August 10, 2006
Molecular aspects of antitumor effects of a new platinum(IV) drugJana Kaspárková, Olga Nováková, Oldrich Vrána, et al.
Chemical Communications (Cambridge, England)|May 4, 2017
Somatostatin receptor-targeted organometallic iridium(iii) complexes as novel theranostic agentsVojtech Novohradsky, Ana Zamora, Albert Gandioso, et al.
Journal of Inorganic Biochemistry|April 24, 2018
New (arene)ruthenium(II) complexes of 4‑aryl‑4H‑naphthopyrans with anticancer and anti-vascular activitiesFlorian Schmitt, Jana Kasparkova, Viktor Brabec, et al.
Pageof 25